ANSWERED ON THIS PAGE:
Russia presents a potentially lucrative market for medical device companies. However, the registration process can be a challenge. Unlike most countries, Russia still relies on in-country testing and clinical data to approve medical devices, even if the device is already sold in other major markets.
With an office in Russia, Emergo stays ahead of regulatory changes and can help you navigate Russia's complex regulatory process.
Medical devices in Russia are regulated by Roszdravnadzor (RZN) under Resolution 1416. You must register your device with RZN prior to selling or distributing your product. Manufacturers must address substantial regulatory requirements, including:
Roszdravnadzor reviews your regulatory submission in two stages. In the first stage, RZN performs a completeness review of your documentation before sending it to an Expertise Center. The Expertise Center will recommend the type of clinical data necessary for your device. RZN will then make the final decision regarding the possibility of your application to procced to stage two.
After you receive a positive response from RZN, you will perform the additional testing and/or clinical trials necessary for your device. You will then resubmit your application to RZN for the stage two review. Once RZN and the Expertise Center approve your application, RZN will issue your Registration Certificate.
Class I manufacturers submit their Russian clinical data in their initial application, and only require one stage of reviews.
For an in-depth overview of the Russia regulatory approval process for medical devices, download our approval process chart that explains how the process works, how long it will take, and
In-country testing and clinical data are the cornerstones of the Russian regulatory process. All manufacturers must test their device in Russia through an officially approved laboratory. Foreign test reports are not accepted, even if the testing was conducted through an internationally recognized lab.
In addition to local testing, all classes of devices require supplemental Russian clinical data. The types of clinical data Roszdravnadzor could require include:
If your device is novel or high-risk, Roszdravnadzor may require human participation clinical trials conducted in Russia.
Navigating Russian bureaucracy and language without the assistance of an experienced local representative can be frustrating. Emergo has the necessary contacts in the Russian market to assist you with all aspects of medical device and IVD company registration in Russia. Here's how we can help:
Emergo's global regulatory experts can help you with medical device market access in Europe and markets worldwide.